Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongmai Fuzhi Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of vascular dementia and related cognitive disorders. It is an empirical prescription developed within the TCM framework and typically consists of multiple herbal ingredients designed to address deficiency, phlegm dampness, and blood stasis—key pathological factors in vascular dementia according to TCM theory. The decoction's mechanism of action is believed to involve inhibition of neuroinflammatory pathways such as the NLRP3 inflammasome, TNF signaling pathway, and toll-like receptor signaling pathway. These actions may reduce neuroinflammation and protect against cognitive decline[1][2][3]. The formula has been studied in clinical settings as an adjunctive therapy for vascular dementia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongmai Fuzhi Decoction.